- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: T315I mutant
Total 620 results
-
Shanghai Chest HospitalCompleted
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Czechia, Germany, Hungary, Canada, United States, Argentina, Australia, Austria, France, Israel, Russian Federation, Spain, Sweden, United Kingdom, Thailand, Belgium, Brazil, Greece, Switzerland, Mexico, Netherlands, Denmark, C... and more
-
MedImmune LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
PfizerActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Netherlands, Korea, Republic of, Italy
-
National Taiwan University HospitalActive, not recruiting
-
Alzamend Neuro, Inc.bioRASI, LLCActive, not recruiting
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Spain, Belgium, United Kingdom, Germany, Australia, Hong Kong, Denmark, France, Japan, Canada, Italy, Austria, Sweden, Switzerland
-
Theseus PharmaceuticalsTerminatedGastrointestinal Diseases | Neoplasms | Neoplasms, Connective and Soft Tissue | Neoplasms by Histologic Type | Gastrointestinal Neoplasms | Neoplasms, Connective Tissue | Digestive System Neoplasm | Digestive System Disease | Gastrointestinal Stromal Tumors (GIST)United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina
-
Daiichi Sankyo Co., Ltd.Daiichi SankyoActive, not recruitingMelanomaKorea, Republic of, China
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsUnited States, France, Argentina, Australia, Belgium, Israel, Italy, Spain
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedLung Cancer | Lung Cancer Metastatic | Lung Adenocarcinoma | Lung Cancer Stage IV | Recurrent Lung Adenocarcinoma | Recurrent Lung CancerUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Genentech, Inc.Active, not recruitingBreast Cancer | Solid TumorUnited States, France, Spain, United Kingdom, Canada
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Taiwan, Canada, Germany, Argentina, Israel, Korea, Republic of, Denmark, France, India, Chile, Netherlands, Singapore, Japan, Mexico
-
Shanghai Fosun Pharmaceutical Industrial Development...Suspended
-
Joaquina BarandaActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | Solid Tumor | Malignant Disease | Relapsed Hematologic MalignancyUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingGlioma | Oligoastrocytoma | Anaplastic Astrocytoma | Oligodendroglioma | Diffuse Astrocytoma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | 1p/19q Co-deletionUnited States
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsActive, not recruitingGlioma | Neoplasms | Glioblastoma | Neoplasms, Neuroepithelial | Central Nervous System Neoplasms | Brain Cancer | Brain Tumor | Ependymoma | Medulloblastoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Ependymoma | Anaplastic Oligodendroglioma | Pineoblastoma | Recurrent Medulloblastoma | CNS Tumor | Pediatric... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; Cyclacel Pharmaceuticals, Inc.Active, not recruiting
-
Dana-Farber Cancer InstitutePfizer; Array BioPharmaActive, not recruiting
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Pancreatic Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Cancer | Esophageal Squamous Cell Cancer | BRAF Mutant Colorectal Cancer | Cervical Squamous Cell Cancer | Lung Squamous Cell CancerCanada, Italy, Spain, Germany, Netherlands, United States, France
-
PMV Pharmaceuticals, IncActive, not recruitingHealthy VolunteersUnited States
-
Massachusetts General HospitalAgios Pharmaceuticals, Inc.CompletedIDH1 Mutation Myeloid NeoplasmsUnited States
-
Massachusetts General HospitalCelgeneCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative...United States
-
Aprea TherapeuticsCompletedMDSUnited States, France
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingRecurrent IDH1/2 Mutated GliomaFrance
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Sabine Mueller, MD, PhDBristol-Myers Squibb; Pacific Pediatric Neuro-Oncology Consortium; The V Foundation...CompletedGlioma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-MutantUnited States, Switzerland
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced CancersUnited States
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMetastatic Non-small Cell Lung CancerUnited States
-
Pierre Fabre MedicamentPfizer; Merck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdCompletedBRAF V600E-mutant Metastatic Colorectal CancerFrance, Italy, United States, Spain, United Kingdom, Belgium, Austria, Japan, Netherlands
-
National Cancer Institute (NCI)CompletedGlioblastoma | Gliosarcoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-MutantUnited States, Canada
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, France, Italy, Korea, Republic of, Spain, United Kingdom, Australia, Canada, Germany, Netherlands, Portugal, Switzerland, Belgium, Sweden
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
Incyte CorporationActive, not recruitingGlioblastoma | Adult-type Diffuse GliomasUnited States, Spain, Italy, United Kingdom, Germany, Japan, France, Netherlands, Denmark
-
Pierre Fabre MedicamentMerck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic Colorectal Cancer | BRAF V600EChina
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation